Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening—A Systematic Review
Karolina Aragon‐Gawinska, Charlotte Mouraux, Tamara Dangouloff, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1377-1377
Open Access | Times Cited: 47

Showing 26-50 of 47 citing articles:

Newborn screening programs for spinal muscular atrophy worldwide in 2023
Eva Vrščaj, Tamara Dangouloff, Damjan Osredkar, et al.
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 6, pp. 1180-1189
Closed Access | Times Cited: 3
Cognition and communication in patients with spinal muscular atrophy: A systematic review
Sanae Akodad, Delphine De Smedt, Simon Baijot, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33677-e33677
Open Access | Times Cited: 2
Taldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular Atrophy
Laurent Servais, Lindsey Lair, Anne M. Connolly, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10273-10273
Open Access | Times Cited: 2
Spinal Muscular Atrophy Update in Best Practices
Mary Schroth, J. Deans, Diana X. Bharucha Goebel, et al.
Neurology Clinical Practice (2024) Vol. 15, Iss. 1
Closed Access | Times Cited: 2
Treatment strategies for patients with spinal muscular atrophy
Liesbeth De Waele, Laurent Servais
Expert Review of Neurotherapeutics (2024), pp. 1-3
Open Access | Times Cited: 2
270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10–12 March, 2023, Hoofddorp, the Netherlands
Emanuela Abiusi, Mar Costa‐Roger, Enrico Bertini, et al.
Neuromuscular Disorders (2023) Vol. 34, pp. 114-122
Open Access | Times Cited: 6
Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan
Shoko Sonehara, Ryosuke Bo, Yoshinori Nambu, et al.
Genes (2023) Vol. 14, Iss. 12, pp. 2211-2211
Open Access | Times Cited: 6
Newborn screening for spinal muscular atrophy - what have we learned?
Alzira Alves de Siqueira Carvalho, Cyril Tychon, Laurent Servais
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 11, pp. 1005-1012
Closed Access | Times Cited: 5
Patients’ Perceptions of Nusinersen Effects according to Their Responder Status
C. Lilien, Eva Vrščaj, Gita Thapaliya, et al.
(2024)
Open Access | Times Cited: 1
Patients’ Perceptions of Nusinersen Effects According to Their Responder Status
C. Lilien, Eva Vrščaj, Gita Thapaliya, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3418-3418
Open Access | Times Cited: 1
Integrated Approaches and Practical Recommendations in Patient Care Identified with 5q Spinal Muscular Atrophy through Newborn Screening
Vanessa Luiza Romanelli Tavares, Rodrigo Holanda Mendonça, Maytê S. Toledo, et al.
Genes (2024) Vol. 15, Iss. 7, pp. 858-858
Open Access | Times Cited: 1
Newborn Screening for Spinal Muscular Atrophy: Variations in Practice and Early Management of Infants with Spinal Muscular Atrophy in the United States
Craig M. Zaidman, Cameron D. Crockett, Ethan Wedge, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 3, pp. 58-58
Open Access | Times Cited: 1
Outcomes for patients in the RESTORE registry with spinal muscular atrophy and four or more SMN2 gene copies treated with onasemnogene abeparvovec
Eduardo F. Tizzano, Susana Quijano-Roy, Laurent Servais, et al.
European Journal of Paediatric Neurology (2024) Vol. 53, pp. 18-24
Open Access | Times Cited: 1
Why should a 5q spinal muscular atrophy neonatal screening program be started?
Michele Michelin Becker, Flávia Nardes, Tamara Dangouloff, et al.
Arquivos de Neuro-Psiquiatria (2024) Vol. 82, Iss. 10, pp. 1-9
Open Access | Times Cited: 1
Spinal muscular atrophy in Brazil: from individual treatment to global management
Laurent Servais, Cristiane Araújo Martins Moreno
Jornal de Pediatria (2024) Vol. 101, Iss. 1, pp. 4-6
Open Access | Times Cited: 1
Concerns About Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy—Reply
Oliver Schwartz, Astrid Pechmann, Janbernd Kirschner
JAMA Pediatrics (2024) Vol. 178, Iss. 9, pp. 955-955
Closed Access
Newborn Screening for Spinal Muscular Atrophy
Elif Yıldırım, Hüseyin Tan
(2024), pp. 89-92
Closed Access
Clinical significance of Spinal Muscular Atrophy carrier detection in Guangdong Province, China: Insights from quantitative polymerase chain reaction and multiplex ligation-dependent probe amplification analysis
Chenxia Xu, Jianming Peng, Xuewei Wu, et al.
Gene Reports (2024) Vol. 37, pp. 102055-102055
Closed Access
Gene therapy for spinal muscular atrophy: timing is key
Laurent Servais
The Lancet Regional Health - Europe (2024) Vol. 47, pp. 101112-101112
Open Access
Newborn screening and rapid genomic diagnosis of neuromuscular diseases
Tamara Dangouloff, H. Lang, Noor Benmhammed, et al.
Journal of Neuromuscular Diseases (2024)
Open Access
Spinal Muscular Atrophy Types, Innovations in Diagnosis and Treatment
Hatice Tankişi, Aycan Ünalp
Journal of Dr Behcet Uz Children s Hospital (2023) Vol. 13, Iss. 3, pp. 146-150
Open Access
Structured Light Plethysmography for Non-Invasive Assessment of Respiratory Pattern in Spinal Muscular Atrophy Type 1
Noemi Brolatti, Federica Trucco, Marta Ferretti, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7553-7553
Open Access
Previous Page - Page 2

Scroll to top